These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29803870)

  • 41. Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness.
    Schuster RM; Fontaine M; Nip E; Zhang H; Hanly A; Evins AE
    Prev Med; 2017 Nov; 104():40-45. PubMed ID: 28242263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Adolescent Cannabis Use Disorders.
    Adams ZW; Marriott BR; Hulvershorn LA; Hinckley JD
    Psychiatr Clin North Am; 2023 Dec; 46(4):775-788. PubMed ID: 37879838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of N-acetylcysteine on cocaine reward and seeking behaviors in a rat model of depression.
    Frankowska M; Jastrzębska J; Nowak E; Białko M; Przegaliński E; Filip M
    Behav Brain Res; 2014 Jun; 266():108-18. PubMed ID: 24613240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study.
    Prado E; Maes M; Piccoli LG; Baracat M; Barbosa DS; Franco O; Dodd S; Berk M; Vargas Nunes SO
    Redox Rep; 2015 Sep; 20(5):215-22. PubMed ID: 25729878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
    Breier A; Liffick E; Hummer TA; Vohs JL; Yang Z; Mehdiyoun NF; Visco AC; Metzler E; Zhang Y; Francis MM
    Schizophr Res; 2018 Sep; 199():395-402. PubMed ID: 29588126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort.
    Rhew IC; Fleming CB; Vander Stoep A; Nicodimos S; Zheng C; McCauley E
    Addiction; 2017 Nov; 112(11):1952-1960. PubMed ID: 28600897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study.
    Feingold D; Rehm J; Lev-Ran S
    Psychiatry Res; 2017 May; 251():225-234. PubMed ID: 28214781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease).
    Sharma S; Gralla J; Ordonez JG; Hurtado ME; Swenson ER; Schoene RB; Kelly JP; Callacondo D; Rivard C; Roncal-Jimenez C; Sirota J; Fuquay R; Jackson BP; Swenson KE; Johnson RJ; Hurtado A; Escudero E
    Respir Physiol Neurobiol; 2017 Dec; 246():1-8. PubMed ID: 28720395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder.
    Magalhães PV; Dean OM; Bush AI; Copolov DL; Weisinger D; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):132-5. PubMed ID: 22212173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.
    González-Ortega I; Alberich S; Echeburúa E; Aizpuru F; Millán E; Vieta E; Matute C; González-Pinto A
    PLoS One; 2015; 10(4):e0123707. PubMed ID: 25875862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-acetylcysteine for major depressive episodes in bipolar disorder.
    Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
    Braz J Psychiatry; 2011 Dec; 33(4):374-8. PubMed ID: 22189927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the Effect of Oral N-acetylcysteine as an Adjuvant Treatment on Clinical Outcomes of Patients with Rheumatoid Arthritis: A Randomized, Double Blind Clinical Trial.
    Batooei M; Tahamoli-Roudsari A; Basiri Z; Yasrebifar F; Shahdoust M; Eshraghi A; Mehrpooya M; Ataei S
    Rev Recent Clin Trials; 2018; 13(2):132-138. PubMed ID: 29521247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solitary cannabis use in adolescence as a correlate and predictor of cannabis problems.
    Creswell KG; Chung T; Clark DB; Martin CS
    Drug Alcohol Depend; 2015 Nov; 156():120-125. PubMed ID: 26365838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effect of prophylactically administered n-acetylcysteine on clinical indicators for tissue oxygenation during hyperoxic ventilation in cardiac risk patients].
    Spies C; Giese C; Meier-Hellmann A; Specht M; Hannemann L; Schaffartzik W; Reinhart K
    Anaesthesist; 1996 Apr; 45(4):343-50. PubMed ID: 8702052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial.
    Mahmoud KM; Ammar AS
    Acta Anaesthesiol Scand; 2011 Sep; 55(8):1015-21. PubMed ID: 22092168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder.
    Brezing CA; Choi CJ; Pavlicova M; Brooks D; Mahony AL; Mariani JJ; Levin FR
    Am J Addict; 2018 Mar; 27(2):101-107. PubMed ID: 29457671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophrenia.
    Koola MM
    Asian J Psychiatr; 2019 Feb; 40():100-102. PubMed ID: 30776665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.